Olecranon septic bursitis managed in an ambulatory setting

Citation
Kb. Laupland et Hd. Davies, Olecranon septic bursitis managed in an ambulatory setting, CLIN INV M, 24(4), 2001, pp. 171-178
Citations number
18
Categorie Soggetti
Research/Laboratory Medicine & Medical Tecnology","Medical Research General Topics
Journal title
CLINICAL AND INVESTIGATIVE MEDICINE-MEDECINE CLINIQUE ET EXPERIMENTALE
ISSN journal
0147958X → ACNP
Volume
24
Issue
4
Year of publication
2001
Pages
171 - 178
Database
ISI
SICI code
0147-958X(200108)24:4<171:OSBMIA>2.0.ZU;2-J
Abstract
Background: The epidemiology, outcome and management of olecranon septic bu rsitis (OSB) have not been described in a large cohort of ambulatory patien ts. Methods: A retrospective study of all 118 cases of OSB presenting over 21 m onths to all regional Home Parenteral Therapy Program clinics in Calgary (r eferral base approximately 1 million). Results: The minimum population annual incidence was 10/100 000. The mean ( and standard deviation) age was 44 (13) years, and males predominated (88%) . One-third of patients had at least one comorbid illness, with preceding i njury in 53% of cases. The most common symptoms were pain (87%), redness (7 7%) and fever or chills (45%). Common signs included erythema (92%), swelli ng (85%), edema (75%), tenderness (59%), fluctuance (50%), heat (36%) and r educed range of motion (27%). Fever (body temperature of greater than or eq ual to 37.8 degreesC) occurred in 20%. Staphylococcus aureus was identified in 88% of culture-proven cases of OBS. The most common antibiotic regimen was sequential intravenous administration of cefazolin (for a median of 4 d ) followed by clindamycin orally (for a median of 8 d). Sixty (51%) patient s required a drainage procedure and only I patient required admission to ho spital. Conclusion: OSB is more common than reported and can be treated suc cessfully in ambulatory settings with sequential intravenous therapy follow ed by oral therapy and drainage in selected cases.